J Refract Surg. 2013 Nov;29(11):777-82. doi: 10.3928/1081597X-20131021-07.
To describe endokeratophakia in which a small incision lenticule extraction (SMILE) lenticule from a myopic patient is implanted into a recipient eye through a small incision to correct hyperopia.
A 23-year-old aphakic woman presented following cataract surgery to remove a childhood congenital cataract with hyperopia of +12.00 -1.50 × 155, corrected distance visual acuity of counting fingers, and exotropia. A SMILE procedure using the VisuMax femto-second laser (Carl Zeiss Meditec, Jena, Germany) was performed on a donor patient with high myopia and the extracted lenticule was stored (power -10.50 diopter sphere, optical zone 5.75 mm, central lenticule thickness 127 μm). In the recipient eye, a pocket lamellar incision was created using the VisuMax SMILE software. The upper interface was separated and the donor lenticule was inserted through the small incision.
One year postoperatively, retinoscopy refraction was +7.50 -3.00 × 150, a spherical equivalent refraction reduction of 5.25 diopters. Mean keratometric power increased by 2.91 diopters. The posterior surface elevation changed significantly with a central bulge into the anterior chamber. Central corneal thickness by Pentacam (Oculus Optikgeräte, Wetzlar, Germany) increased by 121 μm. Central lenticule thickness was 130 μm and central epithelial thickness was 43 μm measured by RTVue OCT (Optovue Inc., Fremont, CA). The cornea remained clear over the 1-year postoperative period.
Endokeratophakia appears to be a viable procedure for correcting hyperopia on the cornea by implantation of an extracted myopic SMILE lenticule from a donor patient. However, posterior surface changes and epithelial remodeling resulted in only 50% of the intended correction. No adverse side effects were observed following implantation of donor tissue for 1 year.
描述通过小切口将来自近视患者的微小切口透镜提取(SMILE)透镜植入受体眼以矫正远视的角膜内屈光手术。
一名 23 岁的无晶状体女性在白内障手术后出现远视,远视度数为+12.00-1.50×155,矫正远视力为手动计数,外斜视。在一名高度近视的供体患者身上进行了 VisuMax 飞秒激光(德国卡尔蔡司 Meditec,耶拿)的 SMILE 手术,提取的透镜被储存(屈光度-10.50 球镜,光学区 5.75mm,中央透镜厚度 127μm)。在受体眼中,使用 VisuMax SMILE 软件创建了一个小袋状层间切口。分离上界面,通过小切口插入供体透镜。
术后 1 年,检影验光屈光度为+7.50-3.00×150,球镜屈光度降低 5.25 屈光度。平均角膜屈光力增加 2.91 屈光度。后表面高度显著改变,中央前凸进入前房。Pentacam(德国 Oculus Optikgeräte,威茨拉尔)测量的中央角膜厚度增加了 121μm。RTVue OCT(美国 Optovue Inc.,弗里蒙特)测量的中央透镜厚度为 130μm,中央上皮厚度为 43μm。术后 1 年期间,角膜保持透明。
通过植入来自供体患者的已提取近视 SMILE 透镜,角膜内屈光手术似乎是矫正角膜远视的可行方法。然而,后表面变化和上皮重塑仅导致 50%的预期矫正。在供体组织植入 1 年后未观察到不良反应。